DTSL yields 2000000.00% · PFE yields 6.13%● Live data
📍 DTSL pulled ahead of the other in Year 1
Combined, DTSL + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DTSL + PFE for your $10,000?
Delivery Technology Solutions, Inc. offers research, development, and marketing of proprietary software for use by the food service industry, primarily in call centers and online ordering for food catering and delivery. The company supplies call center services, and online Web ordering services for its clients, as well as display all relevant information for the agent to handle the call. It provides a turnkey delivery platform to the service industry, which is designed on a customer relationship management (CRM) system and a service integrated technology between customers, call center, and the personal industry provider of choice. The company's solution automatically routes the order electronically to the store nearest the customer's location; and in-house call center offers a suite of services, including inbound-outbound call services and tracking, call recording, and live monitoring. Its call center system is integrated with point of sale (POS) terminals on site at the client stores to provide single order real-time tracking, store delivery staff availability alerts, custom event triggers, and store communication at customer threshold times, as well as management notification through a process of escalation. The company was founded in 2010 and is based in Boca Raton, Florida.
Full DTSL Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.